Antibacterial Compound Sensitizing Multidrug-Resistant Bacteria to Oxidative Stress
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Bacterial infections, particularly those caused by multidrug-resistant strains, pose a significant challenge due to the bacteria's ability to evade host defense mechanisms and develop resistance to oxidative stress, necessitating a new therapeutic approach.
Innovation Solution
A novel antibacterial chemical compound with a specific chemical structure that targets bacterial resistance to oxidative stress, inhibiting intracellular bacterial growth and enhancing the effectiveness of antibiotics against multidrug-resistant bacteria.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional antibiotics are used to treat bacterial infections, then bacterial growth is inhibited, but bacteria develop multidrug resistance
Solution Approach 1:
The compound acts as an intermediary that blocks bacterial efflux pumps, preventing the expulsion of antibiotics and oxidative stress agents from bacterial cells. This mediator function restores the effectiveness of conventional antibiotics by stopping the resistance mechanism without directly killing bacteria, thereby addressing multidrug resistance while maintaining existing therapeutic approaches
Solution Approach 2:
The compound changes the physiological parameters of bacterial cells by inhibiting efflux pump activity, which alters the intracellular concentration of antibiotics and oxidative stress agents. This parameter change (increased intracellular drug retention) sensitizes multidrug-resistant bacteria to oxidative stress and restores antibiotic efficacy without requiring new antibiotic mechanisms
2Reliability
If efflux pumps are blocked to enhance antibiotic effectiveness, then bacterial resistance is reduced, but the complexity of treatment increases
Solution Approach 1:
The compound can be combined with conventional antibiotics in a single pharmaceutical formulation or treatment regimen, merging the efflux pump inhibition function with existing antibiotic therapy. This combination approach enhances antibiotic effectiveness against multidrug-resistant bacteria while maintaining a relatively simple treatment protocol that does not require separate administration steps
3Reliability
If oxidative stress is enhanced to kill intracellular bacteria, then bacterial viability is reduced, but host cell damage may occur
Solution Approach 1:
The compound exhibits selective action by specifically targeting bacterial efflux pumps while sparing host cell mechanisms. By blocking bacterial efflux pumps locally, the compound enables oxidative stress agents to accumulate selectively within bacterial cells rather than throughout the entire host-bacteria system, thereby enhancing bacterial killing efficiency while minimizing host cell exposure and potential damage
Data Source
AI summary
The present invention provides an antibacterial chemical compound, its manufacturing method and its use thereof which acts as antibacterial agents being useful for treating a disease or condition characterized by infectious disease, such as gastroenteritis and invasive non-typhoidal Salmonellosis, and also providing a new therapeutic option for patients infected by the bacteria with the resistance to antibiotics.